N. Ferrara
Molecular Biology · 2000–2019
A researcher in the Science corpus: 30 papers; trusts 39 researchers and is trusted by 66 researchers here, as inferred from the citation graph.
Subfields
- Molecular Biology — 403 citations into it; #409 of 17,836 by trust here, #498 by citations
- Cancer Research — 190 citations into it; #36 of 1,784 by trust here, #95 by citations
- Oncology — 187 citations into it; #115 of 1,698 by trust here, #114 by citations
- Pulmonary and Respiratory Medicine — 69 citations into it
- Ophthalmology — 57 citations into it; #175 of 222 by trust here, #11 by citations
- Radiology, Nuclear Medicine and Imaging — 50 citations into it
- Immunology — 48 citations into it
- Immunology and Allergy — 44 citations into it
Whom N. Ferrara trusts overall
Their strongest outbound trust, strongest first, inferred from their citations.
- Rakesh K. Jain
- David M. Brown
- Peter Carmeliet
- H. Gerber
- R. Kerbel
- G. Bergers
- J. Lecouter
- G. Klement
- G. Semenza
- K. Alitalo
Who trusts N. Ferrara overall
- Rakesh K. Jain
- R. Apte
- G. Bergers
- Peter Carmeliet
- S. Eming
- J. Joyce
- A. Adamis
- R. Roskoski
- H. Gerber
- Alicia S. Chung
Papers from N. Ferrara's perspective
Ordered by how strongly the researchers N. Ferrara trusts endorse each paper. Same corpus, a different order for every researcher.
- Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis (Nature Cell Biology)
- Origins of circulating endothelial cells and endothelial outgrowth from blood. (Journal of Clinical Investigation)
- Dissecting tumour pathophysiology using intravital microscopy (Nature Reviews. Cancer)
- The vascular anatomy of the developing zebrafish: an atlas of embryonic and early larval development. (Developmental Biology)
- Beyond aerobic glycolysis: Transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis (Proceedings of the National Academy of Sciences of the United States of America)
- The present and future role of microfluidics in biomedical research (Nature)
- Innovation: Metabolomics: the apogee of the omics trilogy (Nature reviews. Molecular cell biology)
- Stem and progenitor cells: origins, phenotypes, lineage commitments, and transdifferentiations. (Annual Review of Cell and Developmental Biology)
- Robust systemic transduction with AAV9 vectors in mice: efficient global cardiac gene transfer superior to that of AAV8. (Molecular Therapy)
- The history and future of the fluorescence activated cell sorter and flow cytometry: a view from Stanford. (Clinical Chemistry)
Their papers
- Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. (2004) — 9,988 citations
- The biology of VEGF and its receptors (2003) — 9,751 citations
- Autocrine VEGF signaling is required for vascular homeostasis. (2007) — 1,080 citations
- Discovery and development of bevacizumab, an anti-VEGF antibody for treating cancer (2004) — 2,638 citations
- PDGF-C mediates the angiogenic and tumorigenic properties of fibroblasts associated with tumors refractory to anti-VEGF treatment. (2009) — 618 citations
- VEGF and the quest for tumour angiogenesis factors (2002) — 1,434 citations
- Targeting the tumour vasculature: insights from physiological angiogenesis (2010) — 752 citations
- Bv8 regulates myeloid-cell-dependent tumour angiogenesis (2007) — 645 citations
- Role of vascular endothelial growth factor in regulation of physiological angiogenesis. (2001) — 1,071 citations
- Tumor refractoriness to anti-VEGF treatment is mediated by CD11b+Gr1+ myeloid cells (2007) — 887 citations
- Role of vascular endothelial growth factor in physiologic and pathologic angiogenesis: therapeutic implications. (2002) — 724 citations
- Angiogenesis as a therapeutic target (2005) — 2,677 citations
- Vascular endothelial growth factor: basic science and clinical progress. (2004) — 3,786 citations
- Pharmacology and pharmacodynamics of bevacizumab as monotherapy or in combination with cytotoxic therapy in preclinical studies. (2005) — 645 citations
- Ten years of anti-vascular endothelial growth factor therapy (2016) — 953 citations
- DEVELOPMENT OF RANIBIZUMAB, AN ANTI–VASCULAR ENDOTHELIAL GROWTH FACTOR ANTIGEN BINDING FRAGMENT, AS THERAPY FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION (2006) — 877 citations
- VEGF regulates haematopoietic stem cell survival by an internal autocrine loop mechanism (2002) — 755 citations
- Analysis of Biological Effects and Signaling Properties of Flt-1 (VEGFR-1) and KDR (VEGFR-2) (2001) — 651 citations
- VEGF as a Therapeutic Target in Cancer (2005) — 604 citations
- VEGF in Signaling and Disease: Beyond Discovery and Development (2019) — 2,318 citations